KERX Market Cap History
Below is a table of the KERX market cap history going back to 3/15/2010:

Date KERX Market Cap
3/15/2010155.23M
5/5/2010326.32M
8/3/2010228.03M
10/29/2010315.69M
2/24/2011236.97M
5/9/2011351.61M
8/1/2011318.55M
10/31/2011220.88M
2/23/2012223.72M
5/2/2012111.77M
7/31/2012130.88M
10/31/2012179.10M
2/26/2013539.09M
4/30/2013666.00M
7/24/2013719.98M
10/25/2013889.84M
5/1/20141.34B
7/30/20141.41B
10/31/20141.55B
2/17/20151.23B
4/20/20151.20B
7/22/20151.00B
10/23/2015470.21M
2/22/2016379.04M
4/22/2016544.98M
7/29/2016779.39M
11/4/2016488.48M
2/22/2017513.58M
4/28/2017642.12M
7/20/2017839.56M
10/31/2017772.57M
2/9/2018535.10M
4/30/2018533.56M
7/31/2018510.75M
10/31/2018334.65M

Also see: KERX Shares Outstanding History
and KERX YTD Return
KERX Historical Market Cap:
+9.30% CAGR
KERX Historical Market Cap: +9.30% CAGR

Mouse over chart for data details
3/15/2010 ...10/31/2018
Keryx Biopharmaceuticals is a commercial stage biopharmaceutical company focused on bringing medicines to people with kidney disease. Co.'s marketed product, Auryxia (ferric citrate) tablets, is an orally available, absorbable, iron-based medicine. Auryxia is used for the control of serum phosphorus levels in patients with chronic kidney disease (CKD), on dialysis. Auryxia is also for the treatment of iron deficiency anemia in adults with CKD, not on dialysis. Ferric citrate is also approved in Japan under the trade name Riona and marketed by Co.'s Japanese partner, Japan Tobacco, Inc. and its subsidiary, Torii Pharmaceutical Co., Ltd., and approved in Europe as Fexeric. We show 35 historical shares outstanding datapoints in our KERX shares outstanding history coverage, used to compute KERX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing KERX market cap history over the course of time is important for investors interested in comparing KERX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of KERX versus a peer is one thing; comparing KERX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like KERX can fluctuate over the course of history. With this page we aim to empower investors researching KERX by allowing them to research the KERX market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree KERX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Keryx Biopharmaceuticals (KERX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

KIDS Market Cap History
KIN Market Cap History
KLDO Market Cap History
KMPH Market Cap History
KND Market Cap History
KNTE Market Cap History
KOD Market Cap History
KOOL Market Cap History
KPRX Market Cap History
KPTI Market Cap History
More Healthcare companies »

 

KERX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.